Emotional experiences of family caregivers of children with Dravet syndrome - Publikacja - MOST Wiedzy

Twoje konto

zaloguj

Wyszukiwarka

Emotional experiences of family caregivers of children with Dravet syndrome

Abstrakt

Background: Since the psychosocial implications of Dravet syndrome (DS) are much more serious and far-reaching than in other types of epilepsy, caring for a DS child seriously affects the entire family. This study describes the emotional experiences of family caregivers of DS children and evaluates the way caregiving affects their perceived quality of life.

Methods: An anonymous, self-administered online questionnaire was sent to family caregivers of DS children through the online patient advocacy organisation the Association for People with Severe Refractory Epilepsy DRAVET.PL. It focussed on the psychosocial impact of caregiving for DS children, the perceived burden of caregiving, caregivers’ emotional experiences and feelings related to caregiving and the impact of DS on the perceived quality of life.

Results: Caregivers stressed that caring for a DS child is associated with a significant psychosocial and emotional burden that affects the entire family. Although most caregivers reported that it was the child’s health problems and behavioural and psychological disorders that were the most challenging aspects of caregiving, they were also burdened by the lack of emotional support. As caregivers were profoundly engaged in caregiving, they experienced a variety of distressing emotions, including feelings of helplessness, anxiety and fear, anticipated grief, depression and impulsivity. Many caregivers also reported that their children’s disease disrupted their relationships with their spouses, family and healthy children. As caregivers reported experiencing role overload, physical fatigue and mental exhaustion, they stressed the extent to which caregiving for DS children impaired their quality of life, their social and professional life, and was a source of financial burden.

Conclusions: As this study identified specific burden domains affecting DS caregivers’ well-being family carers often need special attention, support and help. In order to alleviate the humanistic burden of DS carers a bio-psychosocial approach focusing on physical, mental, and psychosocial interventions should include both DS children and their caregivers.

Cytowania

Autor (1)

Cytuj jako

Pełna treść

pobierz publikację
pobrano 17 razy
Wersja publikacji
Submitted Version
Licencja
Creative Commons: CC-BY-NC-ND otwiera się w nowej karcie

Słowa kluczowe

Informacje szczegółowe

Kategoria:
Publikacja w czasopiśmie
Typ:
Publikacja w czasopiśmie
Opublikowano w:
EPILEPSY & BEHAVIOR nr 142,
ISSN: 1525-5050
Rok wydania:
2023
DOI:
Cyfrowy identyfikator dokumentu elektronicznego (otwiera się w nowej karcie) https://doi.org/10.1016/j.yebeh.2023.109193
Bibliografia: test
  1. Dravet C. The core Dravet syndrome phenotype. Epilepsia 2011;52(Suppl 2):3-9. otwiera się w nowej karcie
  2. Brunklaus A, Zuberi SM. Dravet syndrome-from epileptic encephalopathy to channelopathy. Epilepsia 2014;55(7):979-84.
  3. Sanchez-Carpintero R, Patiño-Garcia A, Urrestarazu E. Musicogenic seizures in Dravet syndrome. Dev Med Child Neurol 2013;55(7):668-70.
  4. Verbeek NE, Wassenaar M, van Campen JS, Sonsma A, Gunning B, Knoers N, et al. Seizure precipitants in Dravet syndrome: What events and activities are specifically provocative compared with other epilepsies?. Epilepsy Behav 2015;47:39-44. otwiera się w nowej karcie
  5. Bjurulf B, Reilly C, Hallböök T. Caregiver reported seizure precipitants and measures to prevent seizures in children with Dravet syndrome. Seizure 2022;103:3-10.
  6. De Liso P, Pironi V, Mastrangelo M, Battaglia D, Craiu D, Trivisano M, et al. Fatal Status Epilepticus in Dravet Syndrome. Brain Sci 2020;10(11):889. https://doi. org/10.3390/brainsci10110889. otwiera się w nowej karcie
  7. Wirrell EC, Nabbout R. Recent Advances in the Drug Treatment of Dravet Syndrome. CNS Drugs 2019;33(9):867-81. otwiera się w nowej karcie
  8. Li W, Schneider AL, Scheffer IE. Defining Dravet syndrome: an essential pre- requisite for precision medicine trials. Epilepsia 2021;62:2205-17. otwiera się w nowej karcie
  9. Strzelczyk A, Schubert-Bast S. A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication. CNS Drugs 2022;36(3):217-37. otwiera się w nowej karcie
  10. Lagae L, Brambilla I, Mingorance A, Gibson E, Battersby A. Quality of life and comorbidities associated with Dravet syndrome severity: a multinational cohort survey. Dev Med Child Neurol 2018;60(1):63-72.
  11. Dravet C, Oguni H. Dravet syndrome (severe myoclonic epilepsy in infancy). Handb Clin Neurol 2013;111:627-33. otwiera się w nowej karcie
  12. Strzelczyk A, Kurlemann G, Bast T, Bettendorf U, Kluger G, Mayer T, et al. Exploring the relationships between composite scores of disease severity, seizure-freedom and quality of life in Dravet syndrome. Neurol Res Pract 2022;4:22. https://doi.org/10.1186/s42466-022-00186-9. otwiera się w nowej karcie
  13. Brunklaus A, Ellis R, Reavey E, Forbes GH, Zuberi SM. Prognostic, clinical and demographic features in SCN1A mutationpositive Dravet syndrome. Brain 2012;135:2329-36.
  14. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet 2001;68:1327-32. otwiera się w nowej karcie
  15. Mei D, Cetica V, Marini C, Guerrini R. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies. Epilepsia 2019;60:S2-7.
  16. Bender AC, Morse RP, Scott RC, Holmes GL, Lenck-Santini PP. SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome. Epilepsy Behav 2012;23(3):177-86.
  17. Steel D, Symonds J, Zuberi S, Brunklaus A. Dravet syndrome and its mimics: beyond SCN1A. Epilepsia 2017;58:1807-16. otwiera się w nowej karcie
  18. Sadleir LG, Mountier EI, Gill D, Davis S, Joshi C, DeVile C, et al. Not all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype. Neurology 2017;89(10):1035-42.
  19. Wang JW, Shi XY, Kurahashi H, Hwang SK, Ishii A, Higurashi N, et al. Prevalence of SCN1A mutations in children with suspected Dravet syndrome and intractable childhood epilepsy. Epilepsy Res 2012;102:195-200. otwiera się w nowej karcie
  20. Bremer A, Lossius MI, Nakken KO. Dravet syndrome-considerable delay in making the diagnosis. Acta Neurol Scand 2012;125(5):359-62. otwiera się w nowej karcie
  21. Silvennoinen K, Puvirajasinghe C, Hudgell K, Sidhu MK, Martins Custodio Genomics England Research Consortium H, et al. Late diagnoses of Dravet syndrome: How many individuals are we missing?. Epilepsia Open 2021;6 (4):770-6.
  22. Lo Barco T, Kuchenbuch M, Garcelon N, Neuraz A, Nabbout R. Improving early diagnosis of rare diseases using Natural Language Processing in unstructured medical records: an illustration from Dravet syndrome. Orphanet J Rare Dis 2021;16:309. https://doi.org/10.1186/s13023-021-01936-9. otwiera się w nowej karcie
  23. Strzelczyk A, Schubert-Bast S. Therapeutic advances in Dravet syndrome: a targeted literature review. Expert Rev Neurother 2020;20(10):1065-79.
  24. Samanta D. Changing landscape of Dravet Syndrome management: An overview. Neuropediatrics 2020;51(2):135-45. otwiera się w nowej karcie
  25. Wang YQ, Fang ZX, Zhang YW, Xie LL, Jiang L. Efficacy of the ketogenic diet in patients with Dravet syndrome: A meta-analysis. Seizure 2020;81:36-42. otwiera się w nowej karcie
  26. Kearney J. Sudden unexpected death in dravet syndrome. Epilepsy Curr 2013;13(6):264-5.
  27. Shmuely S, Sisodiya SM, Gunning WB, Sander JW, Thijs RD. Mortality in Dravet syndrome: A review. Epilepsy Behav 2016;64(Pt A):69-74. otwiera się w nowej karcie
  28. Strzelczyk A, Schubert-Bast S, Bast T, Bettendorf U, Fiedler B, Hamer HM, et al. A multicenter, matched case-control analysis comparing burden-of-illness in Dravet syndrome to refractory epilepsy and seizure remission in patients and caregivers in Germany. Epilepsia 2019;60(8):1697-710.
  29. Villas N, Meskis MA, Goodliffe S. Dravet syndrome: Characteristics, comorbidities, and caregiver concerns. Epilepsy Behav 2017;74:81-6.
  30. Brown A, Arpone M, Schneider AL, Micallef S, Anderson VA, Scheffer IE. Cognitive, behavioral, and social functioning in children and adults with Dravet syndrome. Epilepsy Behav 2020;112:. https://doi.org/10.1016/j. yebeh.2020.107319107319. otwiera się w nowej karcie
  31. Jansson JS, Hallböök T, Reilly C. Intellectual functioning and behavior in Dravet syndrome: A systematic review. Epilepsy Behav 2020;108:. https://doi.org/ 10.1016/j.yebeh.2020.107079107079. otwiera się w nowej karcie
  32. Gataullina S, Dulac O. Is epilepsy the cause of comorbidities in Dravet syndrome?. Dev Med Child Neurol 2018;60(1):8. otwiera się w nowej karcie
  33. Ministry of Family and Social Policy. What are the key facts about ''Personal assistant for persons with disabilities"?; 2019. https://www.gov.pl/web/ family/what-are-the-key-facts-about-personal-assistant-for-persons-with- disabilities. otwiera się w nowej karcie
  34. Ministry of Family and Social Policy. 80 million Polish zlotys for respite care. New programme for non-governmental organisations; 2020. https://www. gov.pl/web/family/80-million-polish-zlotys-for-respite-care-new- programme-for-non-governmental-organisations.
  35. Ministerstwo Edukacji. 2020. Rozporzą dzenie Ministra Edukacji Narodowej z dnia 24 lipca 2015 r. w sprawie warunków organizowania kształcenia, wychowania i opieki dla dzieci i młodzie _ zy niepełnosprawnych, niedostosowanych społecznie i zagro _ zonych niedostosowaniem społecznym.
  36. Ministerstwo Zdrowia. 2021. Uchwała nr 110 Rady Ministrów z dnia 24 sierpnia 2021 r. w sprawie przyję cia dokumentu Plan dla Chorób Rzadkich. https://isap.sejm.gov.pl/isap.nsf/DocDetails.xsp?id=WMP20210000883.
  37. Camfield P, Camfield C, Nolan K. Helping families cope with the severe stress of Dravet Syndrome. Can J Neurol Sci 2016;43(Suppl 3):S9-S12.
  38. Jensen MP, Liljenquist KS, Bocell F, Gammaitoni AR, Aron CR, Galer BS, et al. Life impact of caregiving for severe childhood epilepsy: Results of expert panels and caregiver focus groups. Epilepsy Behav 2017;74:135-43. otwiera się w nowej karcie
  39. Jensen MP, Brunklaus A, Dorris L, Zuberi SM, Knupp KG, Galer BS, et al. The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future research. Epilepsy Behav 2017;70(PtA):104-9.
  40. Campbell JD, Whittington MD, Kim CH, VanderVeen GR, Knupp KG, Gammaitoni A. Assessing the impact of caring for a child with Dravet syndrome: Results of a caregiver survey. Epilepsy Behav 2018;80:152-6.
  41. Whittington MD, Knupp KG, Vanderveen G, Kim C, Gammaitoni A, Campbell JD. The direct and indirect costs of Dravet Syndrome. Epilepsy Behav 2018;80:109-13.
  42. Lagae L, Irwin J, Gibson E, Battersby A. Caregiver impact and health service use in high and low severity Dravet syndrome: A multinational cohort study. Seizure 2019;65:72-9.
  43. Nabbout R, Auvin S, Chiron C, Irwin J, Mistry A, Bonner N, et al. Development and content validation of a preliminary core set of patient-and caregiver- relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome. Epilepsy Behav 2018;78:232-42. otwiera się w nowej karcie
  44. Nabbout R, Auvin S, Chiron C, Thiele E, Cross H, Scheffer IE, et al. Zogenix and Adelphi Values study group. Perception of impact of Dravet syndrome on children and caregivers in multiple countries: looking beyond seizures. Dev Med Child Neurol 2019;61(10):1229-36.
  45. Nabbout R, Dirani M, Teng T, Bianic F, Martin M, Holland R, et al. Impact of childhood Dravet syndrome on care givers of patients with DS, a major impact on mothers. Epilepsy Behav 2020;108:. https://doi.org/10.1016/j. yebeh.2020.107094107094. otwiera się w nowej karcie
  46. Aledo-Serrano A, Mingorance A. Análisis del impacto familiar y necesidades del síndrome de Dravet en España. Rev Neurol 2020;70(3):75-83.
  47. Juandó-Prats C, James E, Bilder DA, McNair L, Kenneally N, Helfer J, et al. DRAVET ENGAGE. Parent caregivers of children with Dravet syndrome: Perspectives, needs, and opportunities for clinical research. Epilepsy Behav 2021;122(3):108198. https://doi.org/10.1016/j.yebeh.2021.108198. otwiera się w nowej karcie
  48. Sullivan J, Deighton AM, Vila MC, Szabo SM, Maru B, Gofshteyn JS, et al. The clinical, economic, and humanistic burden of Dravet syndrome -A systematic literature review. Epilepsy Behav 2022;130:. https://doi.org/10.1016/j. yebeh.2022.108661108661. otwiera się w nowej karcie
  49. Irwin J, Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, et al. Socio-economic impact of Dravet syndrome in Germany: A real world study. Value Health 2018;21:S342. https://doi.org/10.1016/j.jval.2018.09.2044. otwiera się w nowej karcie
  50. Strzelczyk A, Kalski M, Bast T, Wiemer-Kruel A, Bettendorf U, Kay L, et al. Burden-of-illness and cost-driving factors in Dravet syndrome patients and carers: A prospective, multicenter study from Germany. Eur J Paediatr Neurol 2019;23(3):392-403.
  51. Nolan KJ, Camfield CS, Camfield PR. Coping with Dravet syndrome: parental experiences with a catastrophic epilepsy. Dev Med Child Neurol 2006;48 (9):761-5.
  52. Gonçalves C, Martins S, Fernandes L. Dravet syndrome: Effects on informal caregivers' mental health and quality of life -A systematic review. Epilepsy Behav 2021;122:. https://doi.org/10.1016/j.yebeh.2021.108206108206. otwiera się w nowej karcie
  53. Brancato G, Macchia S, Murgia M, Signore M, Simeoni G, Blanke K, et al. The Handbook of Recommended Practices for Questionnaire Development and Testing in the European Statistical System, 2005. https://unstats.un.org/unsd/ EconStatKB/KnowledgebaseArticle10364.aspx.
  54. Postma A, Milota M, Jongmans MJ, Brilstra EH, Zinkstok JR. Challenging behavior in children and adolescents with Dravet syndrome: Exploring the lived experiences of parents. Epilepsy Behav 2023;138:. https://doi.org/ 10.1016/j.yebeh.2022.108978108978. otwiera się w nowej karcie
  55. Nolan K, Camfield CS, Camfield PR. Coping with a child with Dravet syndrome: insights from families. J Child Neurol 2008;23(6):690-4.
  56. Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, et al. EpiPaed Study Group. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Epilepsia 2015;56(9):1388-97.
  57. Skluzacek JV, Watts KP, Parsy O, Wical B, Camfield P. Dravet syndrome and parent associations: the IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief. Epilepsia 2011;52 (Suppl2):95-101. https://doi.org/10.1111/j.1528-1167.2011.03012.x. otwiera się w nowej karcie
  58. Strzelczyk A, Schubert-Bast S, Reese JP, Rosenow F, Stephani U, Boor R. Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam. Epilepsy Behav 2014;34:86-91. otwiera się w nowej karcie
  59. Elliott J, McCoy B, Clifford T, Wells GA, Coyle D. Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis. Pharmacoeconomics 2018;36(10):1253-61.
  60. Walkowiak D, Domaradzki J. Are rare diseases overlooked by medical education? Awareness of rare diseases among physicians in Poland: an explanatory study. Orphanet J Rare Dis 2021;16:400. https://doi.org/10.1186/ s13023-021-02023-9. otwiera się w nowej karcie
  61. Domaradzki J, Walkowiak D. Knowledge and attitudes of future healthcare professionals towards rare diseases. Front Genet 2021;12:. https://doi.org/ 10.3389/fgene.2021.639610639610. otwiera się w nowej karcie
  62. Anderson M, Elliott EJ, Zurynski YA. Australian families living with rare disease: experiences of diagnosis, health services use and needs for psychosocial support. Orphanet J Rare Dis 2013;8:22. https://doi.org/ 10.1186/1750-1172-8-22. otwiera się w nowej karcie
  63. Carmichael N, Tsipis J, Windmueller G, Mandel L, Estrella E. ''Is it going to hurt?": the impact of the diagnostic odyssey on children and their families. J Genet Couns 2015;24(2):325-35.
  64. Domaradzki J. Family caregivers' experiences with healthcare services: a case of Huntington disease. Psychiatr Pol 2016;50(2):375-91. otwiera się w nowej karcie
  65. Llubes-Arrià L, Sanromà-Ortíz M, Torné-Ruiz A, Carillo-Álvarez E, García- Expósito J, Roca J. Emotional experience of the diagnostic process of a rare disease and the perception of support systems: A scoping review. J Clin Nurs 2022;31(1-2):20-31.
Weryfikacja:
Brak weryfikacji

wyświetlono 40 razy

Publikacje, które mogą cię zainteresować

Caring for Children with Dravet Syndrome: Exploring the Daily Challenges of Family Caregivers

2023

Ultra-rare ultra-care: The unique burden of ultra rare disease caregiving

2023

Evaluating the challenges and needs of parents caring for children with Williams syndrome: A preliminary study from Poland

2024

Professional activity, gender and disease-related emotions: The impact on parents' experiences in caring for children with phenylketonuria

2023
Meta Tagi